Zydus Lifesciences Q1 FY25 results: PAT up 31%, revenue rises 21%



Zydus Lifesciences Q1 FY25 results: PAT up 31%, revenue rises 21%

Zydus Lifesciences Q1 FY25 results: PAT up 31%, revenue rises 21%

Zydus Lifesciences Q1 FY25 results: PAT up 31%, revenue rises 21%

Zydus Lifesciences Q1 FY25 results: PAT up 31%, revenue rises 21%
Zydus Lifesciences Q1 FY25 results: PAT up 31%, revenue rises 21%
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Equity markets end turbulent week with 1% gain; Sensex up 820 points
Rane (Madras) receives revision in credit ratings from CRISIL

Board of Sky Gold approves fund raising up to Rs 270 cr
Market regulator Sebi plans to launch smaller SIPs and REIT reforms